Featured Research

from universities, journals, and other organizations

Experimental Vaccine Protects Animals From Deadly Ebola Virus; May Prove Effective In Developing The First Human Vaccine

Date:
March 5, 2009
Source:
Southwest Foundation for Biomedical Research
Summary:
Protection against Ebola, one of the world's deadliest viruses, can be achieved by a vaccine produced in insect cells, raising prospects for developing an effective vaccine for humans, according to new research.

Protection against Ebola, one of the world’s deadliest viruses, can be achieved by a vaccine produced in insect cells, raising prospects for developing an effective vaccine for humans, say scientists at the Southwest Foundation for Biomedical Research (SFBR) in San Antonio.

Related Articles


“The findings are significant in that the vaccine is not only extremely safe and effective, but it is also produced by a method already established in the pharmaceutical industry,” says SFBR’s Ricardo Carrion, Ph.D., one of the primary authors of the study. “The ability to produce the vaccine efficiently is attractive in that production can be scaled up quickly in the case of an emergency and doses can be produced economically.”

The new study was published in the January 2009 issue of the journal Virology, and was supported by the National Institutes of Health. Jean Patterson, Ph.D., also of SFBR, participated in the research.

Ebola viruses, which cause severe bleeding and a high fatality rate in up to 90 percent of patients, have no effective treatment or vaccine. Since its first identification in Africa in 1987, Ebola outbreaks have caused some 1,800 human infections and 1,300 deaths. Outbreaks have become increasingly frequent in recent years, and are likely to be caused by contact with infected animals followed by spread among humans through close person-to-person contacts. Ebola viruses cause acute infection in humans, usually within four to 10 days. Symptoms include headache, chill, muscle pain, followed by weight loss, delirium shock, massive bleeding and organ failure leading to death in two to three weeks.

Ebola viruses are considered a dangerous threat to public health because of their high fatality rate, ability to transmit person-to-person, and low lethal infectious dose. Moreover, their potential to be developed into biological weapons causes grave concern for their use as a bioterrorism agent. While some vaccines show protection in non-human primate studies, the strategies used may not be uniformly effective in the general human population due to pre-existing immunity to the virus-based vaccines.

In the new study, a vaccine using Ebola virus-like particles (VLPs) was produced in insect cells using traditional bio-engineering techniques and injected into laboratory mice. A VLP vaccine is based upon proteins produced in the laboratory that assemble into a particle that, to the human immune system, looks like the virus but cannot cause disease.

Two high-dose VLP immunizations produced a high level immune response in mice. And when the twice-immunized mice were given a lethal dose of Ebola virus, they were completely protected from the disease. In contrast, mice that were not immunized had a very low immune system response and became infected. In another experiment, a three low-dose VLP immunization effectively boosted immune system response in mice and protected them against the Ebola virus. This finding is important because it demonstrates that since the vaccine produces immunization in dilute quantities, many more vaccine doses can be generated compared with a poorly immunogenic vaccine.

VLPs are attractive candidates for vaccine development because they lack viral genomic material and thus are not infectious, are safe for broad application, and can be administered repeatedly to vaccinated individuals to boost immune responses.

The findings will be validated in additional animal systems. The vaccine will then undergo FDA safety and efficacy testing prior to use in humans in potentially five years.

Collaborators on the study included Richard Compans, Ph.D., and Chinglai Yang, Ph.D., of the Emory University School of Medicine in Atlanta.


Story Source:

The above story is based on materials provided by Southwest Foundation for Biomedical Research. Note: Materials may be edited for content and length.


Cite This Page:

Southwest Foundation for Biomedical Research. "Experimental Vaccine Protects Animals From Deadly Ebola Virus; May Prove Effective In Developing The First Human Vaccine." ScienceDaily. ScienceDaily, 5 March 2009. <www.sciencedaily.com/releases/2009/02/090227081134.htm>.
Southwest Foundation for Biomedical Research. (2009, March 5). Experimental Vaccine Protects Animals From Deadly Ebola Virus; May Prove Effective In Developing The First Human Vaccine. ScienceDaily. Retrieved December 20, 2014 from www.sciencedaily.com/releases/2009/02/090227081134.htm
Southwest Foundation for Biomedical Research. "Experimental Vaccine Protects Animals From Deadly Ebola Virus; May Prove Effective In Developing The First Human Vaccine." ScienceDaily. www.sciencedaily.com/releases/2009/02/090227081134.htm (accessed December 20, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, December 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Best Tips to Curb Holiday Carbs

The Best Tips to Curb Holiday Carbs

Buzz60 (Dec. 19, 2014) It's hard to resist those delicious but fattening carbs we all crave during the winter months, but there are some ways to stay satisfied without consuming the extra calories. Vanessa Freeman (@VanessaFreeTV) has the details. Video provided by Buzz60
Powered by NewsLook.com
Sierra Leone Bikers Spread the Message to Fight Ebola

Sierra Leone Bikers Spread the Message to Fight Ebola

AFP (Dec. 19, 2014) More than 100 motorcyclists hit the road to spread awareness messages about Ebola. Nearly 7,000 people have now died from the virus, almost all of them in west Africa, according to the World Health Organization. Video provided by AFP
Powered by NewsLook.com
Researchers Test Colombian Village With High Alzheimer's Rates

Researchers Test Colombian Village With High Alzheimer's Rates

AFP (Dec. 19, 2014) In Yarumal, a village in N. Colombia, Alzheimer's has ravaged a disproportionately large number of families. A genetic "curse" that may pave the way for research on how to treat the disease that claims a new victim every four seconds. Duration: 02:42 Video provided by AFP
Powered by NewsLook.com
The Best Protein-Filled Foods to Energize You for the New Year

The Best Protein-Filled Foods to Energize You for the New Year

Buzz60 (Dec. 19, 2014) The new year is coming and nothing will energize you more for 2015 than protein-filled foods. Fitness and nutrition expert John Basedow (@JohnBasedow) gives his favorite high protein foods that will help you build muscle, lose fat and have endless energy. Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins